Phosphoribosyltransferase
From Proteopedia
(Difference between revisions)
| Line 53: | Line 53: | ||
**[[4hib]], [[4hkp]] - hOPRT + inhibitor<br /> | **[[4hib]], [[4hkp]] - hOPRT + inhibitor<br /> | ||
**[[4rv4]] - BaOPRT + PRPP<BR /> | **[[4rv4]] - BaOPRT + PRPP<BR /> | ||
| + | **[[4wml]], [[4wn3] - yOPRT + PRPP<BR /> | ||
**[[1opr]], [[1lh0]] - StOPRT + orotate + PRPP<BR /> | **[[1opr]], [[1lh0]] - StOPRT + orotate + PRPP<BR /> | ||
**[[2ps1]] - yOPRT + orotate + PRPP<BR /> | **[[2ps1]] - yOPRT + orotate + PRPP<BR /> | ||
| + | **[[5hki]] – MtOPRT + Fe-citrate – ''Mycobacterium tuberculosis'' <br /> | ||
| + | **[[5hkf]] - MtOPRT + PRPP<BR /> | ||
| + | **[[5hkl]] - MtOPRT (mutant) + Pi<BR /> | ||
*'''Hypoxanthine-guanine phosphoribosyltransferase''' | *'''Hypoxanthine-guanine phosphoribosyltransferase''' | ||
| Line 143: | Line 147: | ||
*'''Uracil phosphoribosyltransferase''' | *'''Uracil phosphoribosyltransferase''' | ||
| - | **[[1w30]] - MtUPRT <br /> | + | **[[1w30]], [[5e38]] - MtUPRT <br /> |
**[[1bd3]] - TgUPRT (mutant) <br /> | **[[1bd3]] - TgUPRT (mutant) <br /> | ||
**[[1v9s]] - TtUPRT <br /> | **[[1v9s]] - TtUPRT <br /> | ||
| Line 168: | Line 172: | ||
**[[4lza]] – APRT – ''Thermoanaerobacter pseudethanolicus''<br /> | **[[4lza]] – APRT – ''Thermoanaerobacter pseudethanolicus''<br /> | ||
**[[4m0k]] – APRT – ''Rhodothermus marinus''<br /> | **[[4m0k]] – APRT – ''Rhodothermus marinus''<br /> | ||
| - | **[[4mb6]] – | + | **[[4mb6]] – YpAPRT – ''Yersinia pseudotuberculosis''<br /> |
**[[4trb]] – SsAPRT <br /> | **[[4trb]] – SsAPRT <br /> | ||
| Line 178: | Line 182: | ||
**[[1qb8]] - LdAPRT + AMP<br /> | **[[1qb8]] - LdAPRT + AMP<br /> | ||
**[[1ore]], [[1zn8]], [[1zn9]] - hAPRT + AMP<br /> | **[[1ore]], [[1zn8]], [[1zn9]] - hAPRT + AMP<br /> | ||
| + | **[[4x44]], [[4x45]] - hAPRT (mutant) + AMP - human<br /> | ||
| + | **[[5b6h]] - YpAPRT + AMP <br /> | ||
**[[1mzv]] - LtAPRT + AMP<br /> | **[[1mzv]] - LtAPRT + AMP<br /> | ||
**[[4ts7]] - SsAPRT + ADP<br /> | **[[4ts7]] - SsAPRT + ADP<br /> | ||
| Line 186: | Line 192: | ||
*'''Nicotinate mononucleotide:5, 6-dimethylbenzimidazole phosphoribosyltransferase''' | *'''Nicotinate mononucleotide:5, 6-dimethylbenzimidazole phosphoribosyltransferase''' | ||
| - | **[[1l4b]] – | + | **[[1l4b]] – StNN:DBI PRT <br /> |
| - | **[[4kqh]] - | + | **[[4kqh]] - StNN:DBI PRT (mutant)<br /> |
**[[1wx1]] – TtNN:DBI PRT <br /> | **[[1wx1]] – TtNN:DBI PRT <br /> | ||
**[[3u4g]] – PhNN:DBI PRT | **[[3u4g]] – PhNN:DBI PRT | ||
| Line 193: | Line 199: | ||
*Nicotinate mononucleotide:5, 6-dimethylbenzimidazole phosphoribosyltransferase complex | *Nicotinate mononucleotide:5, 6-dimethylbenzimidazole phosphoribosyltransferase complex | ||
| - | **[[1jh8]], [[4kqf]] – | + | **[[1jh8]], [[4kqf]] – StNN:DBI PRT + adenine<br /> |
| - | **[[1l4e]], [[1l4f]], [[1l4g]], [[1l4h]], [[1l4k]], [[1l4l]], [[1l4m]], [[1l4n]], [[1l5f]], [[1l5k]], [[1l5l]], [[1l5m]], [[1l5n]], [[1l5o]] - | + | **[[1l4e]], [[1l4f]], [[1l4g]], [[1l4h]], [[1l4k]], [[1l4l]], [[1l4m]], [[1l4n]], [[1l5f]], [[1l5k]], [[1l5l]], [[1l5m]], [[1l5n]], [[1l5o]] - StNN:DBI PRT + product-aldimine complex<br /> |
| - | **[[1jha]] – | + | **[[1jha]] – StNN:DBI PRT + AMP + nicotinate<br /> |
| - | **[[4kqi]] - | + | **[[4kqi]], [[1dov]] - StNN:DBI PRT (mutant) + nicotinate + α-ribazole phosphate<br /> |
| - | **[[1jhm]] – | + | **[[1jhm]] – StNN:DBI PRT + benzimidazole<br /> |
| - | **[[1jho]] – | + | **[[1jho]] – StNN:DBI PRT + NaMN + benzimidazole<br /> |
| - | **[[1jhp]] – | + | **[[1jhp]], [[1d0s]] – StNN:DBI PRT + benzimidazole derivative<br /> |
| - | **[[1jhq]] - | + | **[[1jhq]] - StNN:DBI PRT + NaMN + benzimidazole derivative<br /> |
| - | **[[1jhr]] - | + | **[[1jhr]] - StNN:DBI PRT + NaMN + hydroxypurine<br /> |
| - | **[[1jhu]] - | + | **[[1jhu]] - StNN:DBI PRT + cresol<br /> |
| - | **[[4kqk]] - | + | **[[4kqk]] - StNN:DBI PRT (mutant) + cresol<br /> |
| - | **[[1jhv]] - | + | **[[1jhv]] - StNN:DBI PRT + nicotinate + cresol<br /> |
| - | **[[1jhx]] - | + | **[[1jhx]] - StNN:DBI PRT + phenol<br /> |
| - | **[[1jhy]] - | + | **[[1jhy]] - StNN:DBI PRT + phenol + nicotinate<br /> |
| - | **[[4kqj]] - | + | **[[4kqj]] - StNN:DBI PRT (mutant) + NaMN + cresol<br /> |
| - | **[[4kqg]] - | + | **[[4kqg]] - StNN:DBI PRT (mutant) + cobamide<br /> |
*'''Anthranilate phosphoribosyltransferase''' | *'''Anthranilate phosphoribosyltransferase''' | ||
| Line 216: | Line 222: | ||
**[[1v8g]], [[2elc]] - TtANPRT <br /> | **[[1v8g]], [[2elc]] - TtANPRT <br /> | ||
**[[1vqu]] - ANPRT – Nostoc<br /> | **[[1vqu]] - ANPRT – Nostoc<br /> | ||
| - | **[[3qr9]] – MtANPRT<br /> | + | **[[3qr9]], [[5c2l]] – MtANPRT<br /> |
| + | **[[4x5a]] - MtANPRT (mutant) <BR /> | ||
**[[4hkm]] - ANPRT – ''Xanthomonas campestris''<br /> | **[[4hkm]] - ANPRT – ''Xanthomonas campestris''<br /> | ||
| - | **[[4gtn]] – | + | **[[4gtn]] – AcANPRT – ''Acinetobacter''<br /> |
| - | *Anthranilate phosphoribosyltransferase complex | + | *Anthranilate phosphoribosyltransferase complex containing anthranilate |
| + | |||
| + | **[[4owm]], [[4own]], [[4owo]], [[4owq]], [[4ows]], [[4owu]], [[4n5v]], 4n93]] - MtANPRT + PRPP + anthranilate derivative<BR /> | ||
| + | **[[4ij1]], [[4m0r]], [[4owv]], [[4n8q]] - MtANPRT + anthranilate derivative <br /> | ||
| + | **[[4x5d]] - MtANPRT (mutant) + anthranilate<BR /> | ||
| + | **[[4x5e]] - MtANPRT (mutant) + anthranilate + POP<BR /> | ||
| + | **[[1zyk]] - SsANPRT + anthranilate + PRPP<BR /> | ||
| + | **[[4giu]], [[4gkm]]- PfANPRT + anthranilate derivative + PRPP<br /> | ||
| + | **[[4yi7]] - AcMtANPRT + anthranilate<BR /> | ||
| + | |||
| + | *Anthranilate phosphoribosyltransferase other complexes | ||
**[[1kgz]] - PcANPRT + PRPP<BR /> | **[[1kgz]] - PcANPRT + PRPP<BR /> | ||
| - | **[[1zvw]] | + | **[[1zvw]], [[5byt]], [[5c1r]], [[5c7s]] - MtANPRT + PRPP<BR /> |
| - | + | **[[4x58]], [[4x59]], [[4x5b]] - MtANPRT (mutant) + PRPP<BR /> | |
| - | **[[ | + | **[[4x5c]] - MtANPRT (mutant) + PRPP + POP<BR /> |
| - | **[[ | + | |
| - | + | ||
| - | + | ||
**[[1zxy]] - SsANPRT + PRPP<BR /> | **[[1zxy]] - SsANPRT + PRPP<BR /> | ||
**[[3gbr]] - SsANPRT (mutant) + PRPP<BR /> | **[[3gbr]] - SsANPRT (mutant) + PRPP<BR /> | ||
| - | **[[1gxb]] - SsANPRT + | + | **[[1gxb]] - SsANPRT + POP<br /> |
**[[2gvq]] - SsANPRT + anthranilate<br /> | **[[2gvq]] - SsANPRT + anthranilate<br /> | ||
| - | **[[3qqs]], [[3qs8]], [[3qsa]], [[3r6c]], [[3r88]], [[3twp]], [[3uu1]] | + | **[[4ztv]], [[5bne]], [[5bo2]], [[5bo3]] - MtANPRT + inhibitor <BR /> |
| - | + | **[[3qqs]], [[3qs8]], [[3qsa]], [[3r6c]], [[3r88]], [[3twp]], [[3uu1]], [[4zof]], [[4zoj]], [[4zok]] - MtANPRT + inhibitor + PRPP<BR /> | |
| - | + | ||
*'''ATP phosphoribosyltransferase''' See [[ATP Phosphoribosyl Transferase]] | *'''ATP phosphoribosyltransferase''' See [[ATP Phosphoribosyl Transferase]] | ||
| Line 248: | Line 261: | ||
**[[2im5]] - NIPRT – ''Porphyromonas gingivalis''<br /> | **[[2im5]] - NIPRT – ''Porphyromonas gingivalis''<br /> | ||
**[[3os4]] - NIPRT – ''Yersinia pestis''<br /> | **[[3os4]] - NIPRT – ''Yersinia pestis''<br /> | ||
| - | **[[4hl7]] - VcNIPRT | + | **[[4hl7]] - VcNIPRT <br /> |
| + | **[[4yub]] - hNIPRT <br /> | ||
*Nicotinate phosphoribosyltransferase complex | *Nicotinate phosphoribosyltransferase complex | ||
| Line 273: | Line 287: | ||
**[[2e5d]] - hNMPRT + nicotinamide<br /> | **[[2e5d]] - hNMPRT + nicotinamide<br /> | ||
**[[3dgr]] - hNMPRT + ADP analog<br /> | **[[3dgr]] - hNMPRT + ADP analog<br /> | ||
| - | **[[4jnm]], [[4jr5]], [[4kfn]], [[4kfo]], [[4kfp]], [[4lts]], [[4lv9]], [[4lva]], [[4lvb]], [[4lvd]], [[4lvf]], [[4lvg]], [[4lww]], [[4m6p]], [[4m6q]], [[4n9b]], [[4n9c]], [[4n9d]], [[4n9e]], [[4l4l]], [[4l4m]], [[4o0z]], [[4o10]], [[4o12]], [[4o13]], [[4o14]], [[4o15]], [[4o16]], [[4o17]], [[4o18]], [[4o19]], [[4o1a]], [[4o1b]], [[4o1c]], [[4o1d]], [[4wq6]] - hNMPRT + inhibitor<br /> | + | **[[4jnm]], [[4jr5]], [[4kfn]], [[4kfo]], [[4kfp]], [[4lts]], [[4lv9]], [[4lva]], [[4lvb]], [[4lvd]], [[4lvf]], [[4lvg]], [[4lww]], [[4m6p]], [[4m6q]], [[4n9b]], [[4n9c]], [[4n9d]], [[4n9e]], [[4l4l]], [[4l4m]], [[4o0z]], [[4o10]], [[4o12]], [[4o13]], [[4o14]], [[4o15]], [[4o16]], [[4o17]], [[4o18]], [[4o19]], [[4o1a]], [[4o1b]], [[4o1c]], [[4o1d]], [[4wq6]], [[4o28]], [[5kit]], [[5u2m]], [[5u2n]], [[5upe]], [[5upf]] - hNMPRT + inhibitor<br /> |
**[[3dhd]], [[3dhf]] - hNMPRT + pyrophosphate + NMN<BR /> | **[[3dhd]], [[3dhf]] - hNMPRT + pyrophosphate + NMN<BR /> | ||
**[[3dkj]], [[3dkl]] - hNMPRT + benzamide + PRPP<BR /> | **[[3dkj]], [[3dkl]] - hNMPRT + benzamide + PRPP<BR /> | ||
Revision as of 08:10, 6 September 2017
| |||||||||||
3D structures of phosphoribosyltransferase
Updated on 06-September-2017
References
- ↑ Sculley DG, Dawson PA, Emmerson BT, Gordon RB. A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Hum Genet. 1992 Nov;90(3):195-207. PMID:1487231
- ↑ Gonzalez-Segura L, Witte JF, McClard RW, Hurley TD. Ternary complex formation and induced asymmetry in orotate phosphoribosyltransferase. Biochemistry. 2007 Dec 11;46(49):14075-86. Epub 2007 Nov 20. PMID:18020427 doi:10.1021/bi701023z
- ↑ Foster AC, Whetsell WO Jr, Bird ED, Schwarcz R. Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res. 1985 Jun 17;336(2):207-14. PMID:3159462
- ↑ Carter D, Donald RG, Roos D, Ullman B. Expression, purification, and characterization of uracil phosphoribosyltransferase from Toxoplasma gondii. Mol Biochem Parasitol. 1997 Aug;87(2):137-44. PMID:9247925
- ↑ . PMID:121011881
- ↑ Castell A, Short FL, Evans GL, Cookson TV, Bulloch EM, Joseph DD, Lee CE, Parker EJ, Baker EN, Lott JS. Substrate capture mechanism of Mycobacterium tuberculosis anthranilate phosphoribosyltransferase provides a mode for inhibition. Biochemistry. 2013 Jan 30. PMID:23363292 doi:http://dx.doi.org/10.1021/bi301387m
- ↑ Pedreno S, Pisco JP, Larrouy-Maumus G, Kelly G, de Carvalho LP. Mechanism of feedback allosteric inhibition of ATP phosphoribosyltransferase. Biochemistry. 2012 Oct 9;51(40):8027-38. doi: 10.1021/bi300808b. Epub 2012 Sep, 27. PMID:22989207 doi:http://dx.doi.org/10.1021/bi300808b
- ↑ Galassi L, Di Stefano M, Brunetti L, Orsomando G, Amici A, Ruggieri S, Magni G. Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis. Biochimie. 2012 Feb;94(2):300-9. doi: 10.1016/j.biochi.2011.06.033. Epub 2011 Jul, 3. PMID:21742010 doi:http://dx.doi.org/10.1016/j.biochi.2011.06.033
- ↑ Imai S. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des. 2009;15(1):20-8. PMID:19149599
- ↑ Tohyama J, Nanba E, Ohno K. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Hum Genet. 1994 Feb;93(2):175-81. PMID:8112742
- ↑ Montecucco F, Cea M, Cagnetta A, Damonte P, Nahimana A, Ballestrero A, Del Rio A, Bruzzone S, Nencioni A. Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders. Curr Top Med Chem. 2013;13(23):2930-8. PMID:24171767
- ↑ Gonzalez-Segura L, Witte JF, McClard RW, Hurley TD. Ternary complex formation and induced asymmetry in orotate phosphoribosyltransferase. Biochemistry. 2007 Dec 11;46(49):14075-86. Epub 2007 Nov 20. PMID:18020427 doi:10.1021/bi701023z

